Rimonabant
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is... more
Product information "Rimonabant"
Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. Target: Cannabinoid Receptor, Acyltransferase, Antibacterial. Smiles: Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1. References: Chu CM, et al, Org Biomol Chem, 2008, 6(18), 3399-3407
| Keywords: | SR141716 |
| Supplier: | TargetMol |
| Supplier-Nr: | T1519L |
Properties
| Application: | Targets cannabinoid receptor 1 (CNR1) |
| MW: | 463.79 D |
| Formula: | C22H21Cl3N4O |
Database Information
| CAS : | 168273-06-1| Matching products |
| KEGG ID : | K04277 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H372, H410 |
| P Phrases: | P260, P264, P270, P273, P314, P391, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed